✦ LIBER ✦

Efficacy of HPA-1a (PlA1)-negative platelets in a patient with post-transfusion purpura

✍ Scribed by Alison Wakoff Loren; Charles S. Abrams

Publisher: John Wiley and Sons
Year: 2004
Tongue: English
Weight: 95 KB
Volume: 76
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.20093

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy of thymosin α1 in patients with

Efficacy of thymosin α1 in patients with chronic hepatitis B: A randomized, controlled trial

✍ Rong-Nan Chien; Yun-Fan Liaw; Tse-Ching Chen; Chau-Ting Yeh; I.-Shyan Sheen 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 107 KB 👁 1 views

Thymosin ␣ 1 (T␣) is an immune modifier that has been shown in a pilot study to be effective for chronic hepatitis B; this requires confirmation. Ninety-eight patients with clinicopathologically proven chronic hepatitis B were randomly allocated to 3 groups: 1) group A received a 26-week course of T

Association of the PD-1.3A allele of the

Association of the PD-1.3A allele of the PDCD1 gene in patients with rheumatoid arthritis negative for rheumatoid factor and the shared epitope

✍ Ludmila Prokunina; Leonid Padyukov; Anna Bennet; Ulf de Faire; Björn Wiman; Jona 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB 👁 3 views

## Abstract ## Objective To study the frequency of allele A of polymorphism PD‐1.3 of the __PDCD1__ gene in patients with rheumatoid arthritis (RA) and its subsets, based on the presence of rheumatoid factor (RF) and the shared epitope (SE) alleles. ## Methods A total of 1,175 patients with RA a

Association of SLC11A1 (NRAMP1) with per

Association of SLC11A1 (NRAMP1) with persistent oligoarticular and polyarticular rheumatoid factor–negative juvenile idiopathic arthritis in Finnish patients: Haplotype analysis in Finnish families

✍ Jonathan A. Runstadler; Hanna Säilä; Anneli Savolainen; Marjatta Leirisalo-Repo; 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 110 KB 👁 1 views

A pilot study to evaluate the safety and

A pilot study to evaluate the safety and efficacy of the long-acting interleukin-1 inhibitor rilonacept (interleukin-1 trap) in patients with familial cold autoinflammatory syndrome

✍ Raphaela Goldbach-Mansky; Sharukh D. Shroff; Mildred Wilson; Christopher Snyder; 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 2 views

Search for genomic imbalances in a cohor

Search for genomic imbalances in a cohort of 20 patients with oral–facial–digital syndromes negative for mutations and large rearrangements in the OFD1 gene

✍ Christel Thauvin-Robinet; Patrick Callier; Brunella Franco; Orsetta Zuffardi; Mu 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 67 KB 👁 2 views

A phase III study of the safety and effi

A phase III study of the safety and efficacy of viramidine versus ribavirin in treatment-naïve patients with chronic hepatitis C: ViSER1 results

✍ Yves Benhamou; Nezam H. Afdhal; David R. Nelson; Mitchell L. Shiffman; Deanine G 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 452 KB 👁 2 views

Pegylated interferon (peg-IFN) and ribavirin (RBV) are effective in eradicating the hepatitis C virus in more than half of patients. However, anemia arising from RBV-induced hemolysis can prompt dose reductions and lower sustained virologic response (SVR) rates. In early clinical trials, Viramidine